Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Arcalyst annual cost?Generic name for ultram?How much is letrozole in nigeria?Ribociclib synthesis patent wo2010020675a1?Fedratinib targegen patent?
See the DrugPatentWatch profile for Bendamustine
Bendamustine is marketed under the trade name Treanda [1]. Another trade name for bendamustine is Bendeka [2].
In addition to Treanda and Bendeka, other brand names for bendamustine include Levact [3].
Treanda is manufactured by Teva Pharmaceuticals [1]. Bendeka is developed by Endocyte and licensed to Acrotech Biopharma [4].
The patent for Treanda has faced challenges. Information on specific patent expiry dates and related litigation can be found on DrugPatentWatch.com [5].
Bendamustine is approved for the treatment of certain types of leukemia and lymphoma [1]. Specifically, it is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) and low-grade follicular lymphoma [1].
Generic versions of bendamustine have entered the market. For instance, a generic version of Treanda is available [6].
Other Questions About Bendamustine :